Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ANET vs GSK✓SelectedUSD · GSKANET vs GSK performance historyLatest closeAs of-11.59%11/20
Stock and ETF performance explorer

ANET vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.2%
GSK return
+6.1%
Excess return
+34.0%
Maximum drawdown
-26.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.6%-0.1%-11.5%-11.6%
7D-15.0%-5.3%-9.7%-16.2%
30D-9.1%-3.7%-5.4%-9.9%
3M-8.8%-7.3%-1.5%-10.0%
6M+19.3%-4.2%+23.6%+18.6%
YTD+27.9%+0.9%+27.1%+33.0%
1Y+40.2%+7.3%+32.9%+44.4%
All+40.2%+6.1%+34.0%+44.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling